Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;54(2):151-153.
doi: 10.5045/br.2019.54.2.151. Epub 2019 Jun 25.

First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia

Da Jung Kim  1 , Seri Jeong  2 , Seom Gim Kong  3 , Ho Sup Lee  1
Affiliations

First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia

Da Jung Kim et al. Blood Res. 2019 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1. Computed tomography scan of the chest. Lung setting view image showed diffuse subtle ground glass opacities in the hemithoraces, and atypical pneumonia such as viral infection, pneumocystis pneumonia, miliary TB, or drug-induced pneumonitis was suspected.
Fig. 2
Fig. 2. Changes in BCR-ABL real-time quantitative PCR (RQ-PCR) results according to antituberculosis medication and CML medication. After antituberculosis medication, BCR-ABL RQ-PCR results remained relatively stable and showed a major molecular response.
See this image and copyright information in PMC

References

    1. Reinwald M, Boch T, Hofmann WK, Buchheidt D. Risk of infectious complications in hemato-oncological patients treated with kinase inhibitors. Biomark Insights. 2016;10(Suppl 3):55–68. - PMC - PubMed
    1. Daniels JM, Vonk-Noordegraaf A, Janssen JJ, Postmus PE, van Altena R. Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia. Eur Respir J. 2009;33:670–672. - PubMed
    1. Kang BW, Lee SJ, Moon JH, et al. Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review. Int J Hematol. 2009;90:383–387. - PubMed
    1. Mattiuzzi GN, Cortes JE, Talpaz M, et al. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res. 2003;9:976–980. - PubMed
    1. García-Muñoz R, Galar A, Moreno C, et al. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825) Leuk Lymphoma. 2007;48:2461–2464. - PubMed